Latest share price

Current

669.80p

Average

+30.80p LSE

+4.82% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

06/12/2018

Oxford BioMedica notes Axovant announcement of feedback from FDA regarding AXO-...

Read more

01/12/2018

Oxford BioMedica notes the longer-term analyses from pivotal Kymriah® trials,...

Read more

23/11/2018

Oxford BioMedica announces new digital framework initiative to streamline the...

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo